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● To perform a retrospective analysis to 
evaluate factors that may predict which men 
with elevated PVRs that were at increased risk 
to develop AUR  
● A retrospective analysis was preformed 
evaluating risk factors including age, prostate 
specific antigen (PSA), post void residual (PVR), 
transrectal ultrasound prostate volume (TRUS) 
of 44 male patients seen at Albert Einstein 
Medical Center who had 2 consecutive post void 
residual (PVR) urine determinations greater than 
100 cc over a 6 month period 
● Exclusion criteria: diabetes, prostate ca, 
urethral strictures, history of any transurethral 
surgery, and anticholinergic use 
● Inclusion criteria: BOO diagnosis, 2 
consecutive PVRs >100cc over a 6 month 
period 
● All data was standardized and using this 
regression analysis, we evaluated patient age 
(mean age 58), post void residual volume 
(mean PVR 177ml), prostate specific antigen 
(mean PSA 1.65 ng/ml) and TRUS prostate 
volume (mean TRUS volume 36cc) with respect 
to the development of acute urinary retention 
(AUR) over a 24 month period 
● 4 of 44 patients (9.1%) developed acute 
urinary retention 
● When analyzing all four factors, prostate 
volume was determined to be the only factor 
that was a statistically significant (p=.003) 
predictor of AUR 
● Studying the coefficients, an increase in 1 
standard deviation of prostate volume 
 (12 cc) resulted in a 19.6% increased risk of 
developing AUR 
● There was a strong correlation between 
increased PSA and larger prostate volume 
(0.787) 
● When performing regression analysis using 
age, PVR, and PSA (excluding prostate 
volume), PSA was proven to be a statistically 
significant predictor of AUR (p=.007) 
● Studying these coefficients, an increase in 
PSA by 1 standard deviation (1.377 ng/ml) 
resulted in a 12.3% increased risk of AUR 
● Performing regression analysis with age, PVR, 
and prostate volume (excluding PSA) further 
increased the statistical significance of larger 
prostate volume resulting in AUR (p<.001) 
● In patients with an elevated PVR, increased 
prostate volume was a statistically significant 
predictor of patients that will develop AUR 
within the next 24 months 
● In the absence of a TRUS prostate volume, 
PSA was an statistically significant alternative 
to predict which patients will develop AUR 
● Age and PVR were not a statistically 
significant predictor of AUR 
● The information uncovered in this study may 
help influence which patients may need 
aggressive and early surgical intervention 
versus more conservative medical therapy to 
not only to manage patient the patient’s 
symptoms but also to prevent the numerous 
sequelae of symptomatic BPH 
